A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in Mexico

✍ Scribed by Teschemaker, A.R.; Neslusan, C.; Puig, A.; Valencia, A.; Johansen, P.; Willis, M.

• Book ID: 122173728
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 80 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.2057